Patient-reported outcomes (PROs) in chronic urticaria
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Patient-reported outcomes (PROs) in chronic urticaria. / Moestrup, Kristian; Ghazanfar, Misbah N.; Thomsen, Simon F.
I: International Journal of Dermatology, Bind 56, Nr. 12, 12.2017, s. 1342-1348.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Patient-reported outcomes (PROs) in chronic urticaria
AU - Moestrup, Kristian
AU - Ghazanfar, Misbah N.
AU - Thomsen, Simon F.
PY - 2017/12
Y1 - 2017/12
N2 - Chronic urticaria is an itching skin disease which persists for more than 6 weeks. Chronic urticaria has great impact on the daily life of the patient, and the fluctuating nature of the symptoms complicates the monitoring and treatment of the disease. Currently, there are no reliable biomarkers to identify and measure disease activity in chronic spontaneous urticaria. Consequently, use of patient-reported outcomes (PROs) is crucial when evaluating and monitoring different aspects of chronic urticaria such as disease activity/severity, disease control, and quality of life. We present an overview of seven different PROs used in chronic urticaria and highlight their strengths, limitations, and use in clinical practice and research.
AB - Chronic urticaria is an itching skin disease which persists for more than 6 weeks. Chronic urticaria has great impact on the daily life of the patient, and the fluctuating nature of the symptoms complicates the monitoring and treatment of the disease. Currently, there are no reliable biomarkers to identify and measure disease activity in chronic spontaneous urticaria. Consequently, use of patient-reported outcomes (PROs) is crucial when evaluating and monitoring different aspects of chronic urticaria such as disease activity/severity, disease control, and quality of life. We present an overview of seven different PROs used in chronic urticaria and highlight their strengths, limitations, and use in clinical practice and research.
U2 - 10.1111/ijd.13668
DO - 10.1111/ijd.13668
M3 - Review
C2 - 28567776
AN - SCOPUS:85020081171
VL - 56
SP - 1342
EP - 1348
JO - International Journal of Dermatology
JF - International Journal of Dermatology
SN - 0011-9059
IS - 12
ER -
ID: 196716158